West Pharmaceutical Services | WST - Equity Capital And Reserves


West Pharmaceutical Services reported $2.99B in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
Align Technology USD 4.15B 100.27M Mar/2026
Avanos Medical USD 782.1M 3.9M Mar/2026
Baxter International USD 6.04B 86M Mar/2026
Becton, Dickinson and Co. USD 24.13B 1.15B Mar/2026
Cerus USD 64.22M 2.76M Dec/2025
Charles River Laboratories USD 2.9B 265.94M Mar/2026
Cooper Companies USD 8.36B 124.7M Dec/2025
Dentsply International USD 1.32B 21M Mar/2026
Haemonetics USD 796.32M 115.13M Mar/2026
ICU Medical USD 2.11B 11.9M Mar/2026
Insulet USD 1.3B 212.6M Mar/2026
Integra LifeSciences USD 1.04B 1.06M Mar/2026
IQVIA Holdings USD 6.22B 282M Mar/2026
J&J USD 81.19B 358M Mar/2026
Medtronic USD 48.99B 128M Dec/2025
Merit Medical Systems USD 1.63B 42.42M Mar/2026
Neogen USD 2.1B 2.09M Dec/2025
OraSure Technologies USD 313.32M 27.5M Mar/2026
Quidel USD 1.85B 69.1M Mar/2026
Repligen USD 2.11B 666K Mar/2026
Rockwell Medical USD 30.41M 1.11M Jun/2025
Solventum Corp USD 4.97B 80M Mar/2026
STAAR Surgical USD 352.37M 8.18M Mar/2026
Terumo JPY 1.58T 62.18B Mar/2026
Utah Medical Products USD 119.27M 1.02M Dec/2025
West Pharmaceutical Services USD 2.99B 185.6M Mar/2026